To further interrogate the mechanisms through which ARIH1 modulates EMT induction and cancer progression, we utilized the miniTurboID system to purify ARIH1-interacting protein and analyzed control (no biotin) and biotin treated samples by mass spectrometry. This evidence concerns the gene ARIH1 and cancer.